MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
OKYO Pharma Limited Ordinary Shares

OKYO

#6045
OKYO Pharma Limited Ordinary Shares
1.71
0.00%
Sector:
Básica:
Profit Currency:
Rango diario
1.71
1.71
Rango anual
1.03
3.20
Cambio diario
0.00%
Monthly Change
-23.32%
6 month change
-24.67%
Cambio anual
+44.92%
Cierres anteriores
1.71
Open
1.71
Bid
Ask
Low
1.71
High
1.71
Volumen
2
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. OKYO
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24

Noticias

Investing Investing
OKYO
2026.02.20
Piper Sandler, OKYO Pharma hissesine Ağırlıklı Al önerisi verdi
Investing Investing
OKYO
2026.02.20
Piper Sandler initiates OKYO Pharma stock with Overweight rating
Investing Investing
OKYO
2026.02.13
OKYO Pharma hisseleri 20 milyon dolarlık halka arz duyurusuyla sert düştü
Investing Investing
OKYO
2026.02.13
OKYO Pharma stock tumbles on $20 million public offering announcement
Investing Investing
OKYO
2026.02.13
OKYO Pharma 20 milyon dolarlık adi hisse senedi halka arzını duyurdu
Investing Investing
OKYO
2026.02.13
OKYO Pharma announces $20 million public offering of ordinary shares
Investing Investing
OKYO
2026.02.11
OKYO Pharma ATM hisse senedi teklifini satış aracısı olarak Leerink Partners’a devretti
Investing Investing
OKYO
2026.02.11
OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent
Investing Investing
OKYO
2026.02.10
OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program
Investing Investing
OKYO
2026.01.30
OKYO Pharma, urcosimod NCP çalışma sonuçlarını ASCRS toplantısında sunacak
Investing Investing
OKYO
2026.01.30
OKYO Pharma to present urcosimod NCP study results at ASCRS meeting
Investing Investing
OKYO
2026.01.29
H.C. Wainwright, OKYO Pharma hissesi için Al tavsiyesini 7 dolar hedef fiyatla yineledi

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd